Form D · Other Technology
Delve Health Inc.
Golden Valley, MN · CIK 0001936499
Offering snapshot reported Jul 7, 2022 · SEC filing
- Reported sold
- $500K Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Jun 17, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 7, 2022 | Initial | $499,999 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-451454
Source: Form D, filed Jul 7, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shane Erickson | Director |
| Wessam Sonbol | Director, Executive |
| Tamer Swidan | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
8100 Wayzata Blvd.
Golden Valley, MN, 55426
Golden Valley, MN, 55426